Company profile

iSchemaView

iSchemaView has 1 AI-enabled medical device on the FDA list. The first decision was on July 16, 2025 and the most recent on July 16, 2025 (Rapid CTA 360). Its most common review panel is Radiology (1 device).

1AI devices

2025First decision

2025Latest decision

1Specialties

Timeline

July 16, 2025 · 510(k) K251151Rapid CTA 360 · Radiology · QAS